Drug Targets

Study identifies blood proteins that indicate which patients with iMCD are most likely to benefit from siltuximab

Nanobody-based tool may help researchers design drugs to target “undruggable” proteins involved in chronic diseases

Super-enhancers are a major contributor to pancreatic ductal adenocarcinoma progression  

Researchers report that levels of a single molecule predict whether a patient has subtype 1 or subtype 2 of the disease

Case Western Reserve researchers uncover novel drug targets by piecing together receptor structures